Financial reports
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
24 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
Current reports
8-K
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
12 Mar 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
8-K
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
5 Feb 24
8-K
Regulation FD Disclosure
1 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
15 Sep 23
8-K
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
13 Jul 23
8-K
Entry into a Material Definitive Agreement
14 Apr 23
8-K
Other Events
6 Apr 23
8-K
Material Modifications to Rights of Security Holders
5 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
9 Nov 22
Registration and prospectus
S-8
Registration of securities for employees
15 Nov 23
424B5
Prospectus supplement for primary offering
23 Aug 23
424B5
Prospectus supplement for primary offering
12 Jul 23
424B5
Prospectus supplement for primary offering
11 Jul 23
424B5
Prospectus supplement for primary offering
15 May 23
424B2
Prospectus for primary offering
14 Apr 23
S-8
Registration of securities for employees
28 Mar 23
S-3/A
Shelf registration (amended)
13 Feb 23
S-3
Shelf registration
7 Feb 23
POS AM
Prospectus update (post-effective amendment)
30 Sep 22
Proxies
DEF 14A
Definitive proxy
4 Aug 23
DEF 14A
Definitive proxy
23 Sep 22
PRE 14A
Preliminary proxy
5 Aug 22
DEFA14A
Additional proxy soliciting materials
12 Aug 21
DEFA14A
Additional proxy soliciting materials
19 Jul 21
DEF 14A
Definitive proxy
7 Jul 21
PRE 14A
Preliminary proxy
25 Jun 21
DEF 14A
Definitive proxy
23 Dec 19
PRE 14A
Preliminary proxy
13 Dec 19
DEFA14A
Additional proxy soliciting materials
1 Nov 19
Other
EFFECT
Notice of effectiveness
15 Feb 23
CORRESP
Correspondence with SEC
13 Feb 23
UPLOAD
Letter from SEC
10 Feb 23
EFFECT
Notice of effectiveness
5 Oct 22
EFFECT
Notice of effectiveness
17 Jun 22
CORRESP
Correspondence with SEC
13 Jun 22
UPLOAD
Letter from SEC
20 May 22
EFFECT
Notice of effectiveness
5 Nov 21
CERT
Certification of approval for exchange listing
4 Nov 21
CORRESP
Correspondence with SEC
4 Nov 21
Ownership
4
Francisco Silva
20 Mar 24
4
LANCE ALSTODT
20 Mar 24
SC 13D/A
Broadrick Dale
6 Mar 24
SC 13D/A
Silva Francisco
15 Feb 24
SC 13D/A
ALSTODT LANCE
15 Feb 24
4
David A Rosa
15 Feb 24
4
Patrick F. Williams
15 Feb 24
4
Nickolay V. Kukekov
15 Feb 24
4
Robert Paccasassi
15 Feb 24
4
Robert Eugene Kristal
15 Feb 24